Bridge Medicines is a biotechnology firm that develops and commercializes therapies for the treatment of cancer and infectious diseases.
Business Model:
Revenue: $0
Employees: 51-200
Address: -
City: New York
State: NY
Zip: 10001
Country: US
Bridge Medicines is a biotechnology firm that develops and commercializes therapies for the treatment of cancer and infectious diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2016 | Venture Round | 3 | - |
Bay City Capital Deerfield Takeda Bay City Capital Deerfield Takeda |
11/2020 | Equity | 3 | $10M |
Bay City Capital Deerfield Takeda Bay City Capital Deerfield Takeda |
10/2016 | Venture Round | 3 | - |
Bay City Capital Deerfield Takeda Bay City Capital Deerfield Takeda |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|